Coronavirus Update: CureVac Joins mRNA Vaccines Competitors, Beijing In Lockdown Again

Plus: Hanmi Investigates Oral COVID-19 Vaccine

 
• By Scrip Team

CureVac starts mRNA vaccine trial, Interprotein uses AI in drug discovery and South Korea's Chong Kun and Hanmi make clinical progress.    

Beijing_Queue_Testing
Beijing, China: People queue to be tested for coronavirus after a new COVID-19 outbreak in the south of the city.

More from COVID-19

More from Scrip